BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14575012)

  • 1. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2001; 58(11):953-5. PubMed ID: 11987834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and EUROASPIRE III surveys.
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Surowiec S; Wolfshaut R; Loster M; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):970-7. PubMed ID: 19784901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):956-63. PubMed ID: 11987835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New beta-blockers in the treatment of chronic ischaemic heart disease].
    Jankowski P; Kawecka-Jaszcz K; Jastrzebski M
    Przegl Lek; 2004; 61(9):955-61. PubMed ID: 15803908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].
    de Velasco JA; Cosín J; de Oya M; de Teresa E;
    Rev Esp Cardiol; 2004 Feb; 57(2):146-54. PubMed ID: 14967110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention and cardiac rehabilitation in Spain. Section of Preventive Cardiology].
    Plaza Pérez I; Velasco Rami JA; Maroto Montero JM
    Rev Esp Cardiol; 1996 Aug; 49(8):549-53. PubMed ID: 8756199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
    Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
    Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention of ischemic heart disease. A questionnaire study and suggestions to improved cooperation between hospitals and general practice].
    Bech J; Helqvist S; Hansen H; Friis J; Jacobsen J; Hildebrandt PR
    Ugeskr Laeger; 1999 Jun; 161(24):3650-4. PubMed ID: 10485222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of medical university in modern prevention of cardiovascular diseases. Examples from Medical University of Gdańsk].
    Zdrojewski T; Wierucki L; Ignaszewska-Wyrzykowska A; Zarzeczna-Baran M; Wojdak-Haasa E; Mogilnaya I; Narkiewicz K; Szczech R; Rutkowski M; Bandosz P; Januszko W; Krupa-Wojciechowska B; Wyrzykowski B
    Przegl Lek; 2005; 62 Suppl 3():3-7. PubMed ID: 16521909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stop the pain! A nation-wide quality improvement programme in paediatric oncology pain control.
    Zernikow B; Hasan C; Hechler T; Huebner B; Gordon D; Michel E
    Eur J Pain; 2008 Oct; 12(7):819-33. PubMed ID: 18222100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
    Harats D; Leibovitz E; Maislos M; Wolfovitz E; Chajek-Shaul T; Leitersdorf E; Gavish D; Gerber Y; Goldbourt U;
    Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESC Study Group of Sports Cardiology: recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease.
    ; Börjesson M; Assanelli D; Carré F; Dugmore D; Panhuyzen-Goedkoop NM; Seiler C; Senden J; Solberg EE
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):137-49. PubMed ID: 16575266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.